| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 05/25/2005 | EP0813416B1 Reduction of infarct volume using citicoline |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 05/25/2005 | CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 05/25/2005 | CN1618462A Compositions of SOD and vetetative medicine or its extractives, and its prepn. method |
| 05/25/2005 | CN1618461A Composition of nano-SOD and vegetative medicine or its extractives, and its prepn. method |
| 05/25/2005 | CN1618460A Composition of SOD and animal medicine or its extractives, and its prepn. method |
| 05/25/2005 | CN1618439A Broad-specturm medicine for treating snake venom poisoning |
| 05/25/2005 | CN1618435A Oral liquor for promoting-blood circulation and removing blood stasis contg. Radix astragali and ginseng |
| 05/25/2005 | CN1203090C Cyclic bonding inhibitor |
| 05/24/2005 | CA2324306C Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/18/2005 | EP1530476A1 Use of reboxetine for the treatment of hot flashes |
| 05/18/2005 | EP1317430B1 (2-azabicyclo [2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | CN1617715A Treating muscle wasting with selective androgen receptor modulators |
| 05/18/2005 | CN1616461A Method for producing glabridin product |
| 05/18/2005 | CN1615946A Anti-senility plaster |
| 05/18/2005 | CN1615884A Use of lycopene in producing medicine |
| 05/18/2005 | CN1615867A Naloxone hydrchloride freeze-dried powder preparation for injection |
| 05/18/2005 | CN1615838A Composition containing dicaffeoyl quinic acid and its preparing method |
| 05/18/2005 | CN1615836A Rubidate soft capsule and its preparing method |
| 05/18/2005 | CN1615828A Garlicin injection emulsion and its preparing method |
| 05/18/2005 | CN1202103C Preparation method of red sageroot total phenolic acid |
| 05/18/2005 | CN1201763C Lead-removing health food |
| 05/17/2005 | US6894069 Antihypoxic agent, antiischemic agents; anticonvulsants; respiratory system disorders for infants; administering 2-iminobiotin as nitric oxide synthase inhibitor |
| 05/12/2005 | US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | US20050101546 Increased solubility flavanolignan preparations |
| 05/12/2005 | US20050100534 firoin and firoin-A from extremophilic microorganisms ; active protection and stabilization of skin cells and their organic constituents (proteins, enzymes, membranes, nucleic acids or antioxidants); against damaging environmental influences, UV radiation. |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | CN1615144A A composition for treating neurocerebrovascular disorders |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/06/2005 | WO2005039602A1 Pharmacologically functional water and use thereof |
| 05/06/2005 | WO2003018606A3 Casein derived peptides and uses thereof in therapy |
| 05/05/2005 | US20050095304 Composition and method for smoke detoxification |
| 05/05/2005 | US20050095291 Tamper-resistant oral opioid agonist formulations |
| 05/04/2005 | EP1527777A1 Composition with antioxidant properties comprising an ester of ascorbic acid and a benzoyl rest |
| 05/04/2005 | EP1527159A1 Probiotic propionibacterium jensenii 702 |
| 05/04/2005 | EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 05/04/2005 | EP1377164A4 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 05/04/2005 | CN1611226A CMSVP beauty and free-radical removing function |
| 05/04/2005 | CN1611225A Swallow foot beauty and free radical cleaning function |
| 05/04/2005 | CN1199644C Medicine for treatment of accidental extravasation of anthryracyclines |
| 05/03/2005 | US6887891 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 05/03/2005 | US6887501 Isolated from cocoa beans; solvent extraction; nitric oxide synthase/lipoxygenase/cyclooxygenase modulators |
| 04/28/2005 | WO2005037286A1 Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | US20050090489 An alpha hydroxy acid or a retinoid as a bacterial fermentation product of a novel Streptomyces strain; topical antiwrinkle agents |
| 04/28/2005 | US20050089499 Forming a fermentation broth from plants inoculation with microorganisms and fermenttion to produce active component for use on skin and hair |
| 04/28/2005 | US20050087198 Method for systemic drug delivery through the nail |
| 04/28/2005 | CA2540195A1 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 04/27/2005 | EP1524912A1 Compositions comprising lactoferrin |
| 04/27/2005 | EP1037596B1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 04/27/2005 | CN1610691A 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 04/27/2005 | CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2005 | CN1198639C Immune enhancing compositions |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/26/2005 | US6884773 Modified hemoglobins, including nitrosylhemoglobins, and uses thereof |
| 04/26/2005 | CA2326072C Condensate of sar abolisher, producing method thereof, and sar abolisher powder |
| 04/21/2005 | WO2005035477A1 Method of stabilizing compound having quinone skeleton and stabilized composition |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | US20050085860 Transdermal/transmucosal preparations for electroporation |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/20/2005 | EP1524270A1 Sulfur-containing proanthocyanidin oligomer composition and process for producing the same |
| 04/20/2005 | EP1524263A1 prodrugs containing cycloalkene derivatives |
| 04/20/2005 | EP1523465A1 An hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| 04/20/2005 | EP1523312A1 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 04/20/2005 | CN1607932A Methods for improving the aesthetic appearance of skin |
| 04/20/2005 | CN1607206A Cyclo-glycosyl amino acid, its preparation method and usage in preventing and curing heavy metal poisoning |
| 04/20/2005 | CN1197972C Process for producing Lycopen |
| 04/20/2005 | CN1197586C 原花青素复合物 Proanthocyanidins complex |
| 04/14/2005 | WO2005033254A1 Body fat burn spurring perfume composition |
| 04/14/2005 | WO2005033054A1 Reduced coenzyme q10 crystal excelling in stability and composition containing reduced coenzyme q10 crystal |
| 04/14/2005 | WO2005032569A1 Medicinal composition |
| 04/14/2005 | WO2005032543A1 Hypnotic composition |
| 04/14/2005 | WO2003051287A3 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 04/14/2005 | US20050080120 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body |
| 04/14/2005 | US20050080051 for the treatment of hyperlipidemia and blood coagulation disorders; phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, or phosphatidic acid; dyslipidemia and atherosclerosis |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | US20050079167 Surface treated active carbon; controlling particle size, porosity |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1196136B1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 04/13/2005 | CN1606563A Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 04/13/2005 | CN1196693C Neutralizing agent for toxin of microorganism belonging to genus clostridium |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878376 Modulate immunology response |
| 04/07/2005 | WO2005030975A1 METHOD OF PREPARING α-GLYCOSYLISOQUERCITRIN, INTERMEDIATE THEREFOR, AND BY-PRODUCT |
| 04/07/2005 | WO2005030721A1 Piperidine derivative |
| 04/07/2005 | WO2005030233A1 Active oxygen scavenging agent and process for producing the same |
| 04/07/2005 | WO2005029980A1 Composition with relieved unpleasant odor or taste of cysteines |
| 04/07/2005 | US20050075401 Active oxygen scavenging composition including citrulline |
| 04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 04/07/2005 | US20050074498 Perforated microstructure; flowability, dispersibility; stable aerosols; respiratory inhalants |
| 04/06/2005 | EP1519961A1 Low molecular weight oversulfated polysaccharide |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP1519746A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 04/06/2005 | EP1214084B1 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 04/06/2005 | EP1006964B1 Intrauterine chemical necrosing compositions and apparatus |